Nanobots that patrol our bodies, killer immune cells hunting and destroying cancer cells, biological scissors that cut out defective genes: these are just some of technologies that Cambridge researchers are developing which are set to revolutionise medicine in the future.
How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’? Professor Chris Lowe, inaugural Director of the Cambridge Academy of Therapeutic Sciences, takes the long view on the future of therapeutics.
Cambridge Academy of Therapeutic Sciences aims to create world-leading industry-academia collaborations09 Mar 2017
The Cambridge Academy of Therapeutic Sciences (CATS), a new initiative that aims to establish a world-leading platform for collaboration between academia and industry in the development of therapeutics, will be launched today by the Vice-Chancellor of the University of Cambridge.
The Institute has been recognised for its initiative, innovation and originality.
The recently announced merger of the Department of Chemical Engineering and the Institute of Biotechnology heralds a new dimension for research and teaching opportunities in Cambridge.